<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000551.v1.p1" parentStudy="phs000551.v1.p1" createDate="2012-10-01" modDate="2013-12-02">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Geoffrey Ginsburg, MD, PhD</td><td>Institute for Genome Science and Policy, Duke University, Durham, NC, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Gene expression in CAD</StudyNameEntrez>
	<StudyNameReportPage>Gene Expression Signatures in CATHGEN</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n = 250) after their index catheterization and age-, sex-, and race-matched controls (n = 250) who were free of death/MI &#62; 2 years after cardiac catheterization was identified as part of the MURDOCK Horizon 1 Cardiovascular Disease Study.21 Sufficient RNA for microarray analysis was available in 447 members of this cohort.</p> <p>Observational cohort: 224 sequential CATHGEN samples were selected for whole blood RNA analysis, of which, 191 had sufficient RNA for microarray analysis.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>For both cohorts, subjects consented to participation in the Catheterization Genetics (<a href="http://cathgen.duhs.duke.edu">CATHGEN</a>) biorepository which has banked whole blood RNA in PAXgene&#174; blood tubes from Duke University Medical Center patients at the time of cardiac catheterization.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="20826242"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23831034"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Cardiovascular Diseases"/>
		<Disease vocab_source="MESH" vocab_term="Myocardial Infarction"/>
		<Disease vocab_source="MESH" vocab_term="Coronary Artery Disease"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Geoffrey Ginsburg, MD, PhD</AttName>
			<Institution>Institute for Genome Science and Policy, Duke University, Durham, NC, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-CVD-IRB" longName="Disease-Specific (Cardiovascular Disease, IRB)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIGMS</DacName>
      <DacFullName>National Institute of General Medical Sciences DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000551.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>6</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000551.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000551.v1.p1" FileName="Voora_CATHGEN_DUC_final_7.12.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Cardiovascular Disease, IRB)</ConsentName>
        <ConsentAbbrev>DS-CVD-IRB</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cardiovascular Disease.
Requestor must provide documentation of local IRB approval.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
